MACROH2A1 and myelodysplastic syndrome: Here, we show that the histone variant macroH2A1.1, which is downregulated in a subset of patients with MDS, profoundly affects the survival and differentiation of murine HSCs/HPCs in vivo and human leukemic cell lines in vitro.